ALLR
Allarity Therapeutics Inc
NASDAQ: ALLR · HEALTHCARE · BIOTECHNOLOGY
$1.35
-2.17% today
Updated 2026-04-30
Market cap
$21.83M
P/E ratio
—
P/S ratio
68.22x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
0.2M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$9.75
+622.22%
12-Month target
$1.21
-10.37%
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.24M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $320000.00 | $320000.00 |
| Net income | $-16.06M | $-11.90M | $-24.52M | $-11.23M | $-3.37M |
| EPS | — | — | — | — | $-0.78 |
| Free cash flow | $-16.84M | $-12.74M | $-17.65M | $-14.83M | $-3.24M |
| Profit margin | — | — | — | -3,509.69% | — |
Peer comparison
Smart narrative
Allarity Therapeutics Inc trades at $1.35. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $320000.00.
Frequently asked questions
What is Allarity Therapeutics Inc's stock price?
Allarity Therapeutics Inc (ALLR) trades at $1.35.
Is Allarity Therapeutics Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of Allarity Therapeutics Inc (ALLR)?
The analyst target price is $9.75, representing +622.2% upside from the current price of $1.35.
What is Allarity Therapeutics Inc's revenue?
TTM revenue is $320000.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio68.22x
ROE-103.80%
Beta0.01
50D MA$1.16
200D MA$1.22
Shares out0.02B
Float0.02B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—